Organization
Xentria
3 clinical trials
Clinical trial
A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® Sourced From the European Union and United States in Healthy Male ParticipantsStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary ManifestationsStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary InvolvementStatus: , Estimated PCD: 2029-01-01